Viewing data from:

NOREPINEPHRINE BITARTRATE

ANDA

NOREPINEPHRINE BITARTRATE | A216272 | NEPHRON PHARMACEUTICALS CORPORATION

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LEVOPHED(TE code: AP)

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

CHEMPACIFIC CORPNOREPINEPHRINE BITARTRATE

DMF 163442002

HARMAN FINOCHEM LTDNOREPINEPHRINE BITARTRATE USP

DMF 331272018

SUN PHARMACEUTICAL INDUSTRIES LTDNOREPINEPHRINE BITARTRATE USP

DMF 351842021

ZHEJIANG BOXIAO BIOPHARMACEUTICAL CO LTDNOREPINEPHRINE BITARTRATE (NON-STERILE, ACTIVE PHARMACEUTICAL INGREDIENT)

DMF 400172024

WUHAN WUYAO PHARMACEUTICAL CO LTDInactiveNOREPINEPHRINE BITARTRATE USP, NON-STERILE, BULK DRUG

DMF 153672001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 1MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 11, 2026

No patent or exclusivity listings for this strength.

Change History (1)

Recent changes detected for this application.

ADDED7/1/2026

Nephron added norepinephrine bitartrate (NDA 216272, Supplement 001) to the FDA product database.

New: New record